Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition
- 13 January 2017
- journal article
- case report
- Published by Elsevier BV in Lung Cancer
- Vol. 105, 14-16
- https://doi.org/10.1016/j.lungcan.2017.01.005
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute Midcareer Investigator Award (K24CA201543-01)
This publication has 4 references indexed in Scilit:
- Transformation to SCLC after Treatment with the ALK Inhibitor AlectinibJournal of Thoracic Oncology, 2016
- EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non–Small-Cell Carcinoma With Squamous HistologyJournal of Clinical Oncology, 2015
- Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR InhibitionJournal of Thoracic Oncology, 2015
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR InhibitorsScience Translational Medicine, 2011